[1]
“Effectiveness and Safety of GLP-1 Receptor Agonists in Cardiovascular Outcomes: A Systematic Review and Meta-Analysis”, IJRDT, vol. 3, no. 4, Jan. 2026, doi: 10.62218/ijrdt.v1i4.145.